Changchun, China

Wei Kong

This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: Changchun Bcht Biotechnology Co., Jilin University. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Kong. Retrieved from https://idiyas.com/inventor/wei-kong-8dpg5q4l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Wei Kong

Introduction: Wei Kong, a pioneering inventor hailing from Changchun, China, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Wei Kong's latest patents include a revolutionary AI-powered healthcare device designed to improve patient monitoring and a sustainable energy solution that harnesses solar power more efficiently.

Career Highlights: Throughout his illustrious career, Wei Kong has been recognized for his innovative spirit and dedication to creating solutions that address pressing global challenges. His work has earned him multiple awards and accolades in the tech industry.

Collaborations: Wei Kong has collaborated with leading research institutions and universities to further develop his inventions. His partnerships have led to the successful implementation of cutting-edge technologies in various sectors.

Conclusion: Wei Kong's relentless pursuit of innovation and commitment to creating a positive impact on society through his inventions solidify his position as a trailblazer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…